StockData
BrightSpring Health Services, Inc. logo

BrightSpring Health Services, Inc. (BTSG) KPIs and segments

BTSGNasdaqServices-Home Health Care ServicesFiscal year ends December 31Also trades as BTSGU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3051% above fair value
$68.34−1.49 (-2.13%)

Close on Nov 18, 2026Market cap $13.60BP/E 37.1Yield –

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của BrightSpring Health Services · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của BrightSpring Health Services: 44 chỉ số vận hành, trong đó có Prescriptions Dispensed, Revenue per Script và Gross Profit per Script, lấy từ 43 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Pharmacy Solutions($M)8
3,7323,4073,1713,1572,9672,7902,5322,3972,2662,1151,9771,786
Products($M)
3,7323,4073,1713,1572,9672,7902,5322,3972,2662,1141,977
Medicare Part D($M)
1,2471,1501,0741,1201,0581,008911850826770756516
Commercial Insurance($M)
1,1841,054959880818742675666619570504468
Medicare Part C($M)
708654602641593556488426406378337418
Medicaid($M)
376339309301287266238228214200187178
Medicare Part A($M)
135136138151143139140147142128129139
Private and Other($M)
6456.168.844.148.260.36159.641.752.345.849.9
Medicare Part B($M)
18.118.320.319.518.718.719.519.916.816.716.916.1
Provider Services($M)8
481466442394367358346350336324309589
Services($M)
481466442394367358346350336324309
Medicare Part A($M)
184174171146127126122126114108105106
Medicaid($M)
10697.397.110012888.585.18684.983.982.7336
Medicare Part C($M)
66.966.864.639.628.834.632.633.63628.120.221.6
Commercial Insurance($M)
61.35954.951.951.344.141.443.141.941.941.137.2
Private and Other($M)
58.957.153.154.43063.262.954.354.754.152.681.7
Medicare Part B($M)
3.6012.31.501.801.701.401.506.903.708.106.905.70
Medicare Part D($M)
0.40
Products($M)
3,7323,4073,1713,1572,9672,7902,5322,3972,2662,1141,9771,785
Medicare Part D($M)
1,2471,1501,0741,1201,0581,008911850826770756516
Commercial Insurance($M)
1,2461,1131,014932870786716709661612546505
Medicare Part C($M)
775721667681622590520460442406357439
Medicaid($M)
482437406402416355323314299284270514
Services($M)
481466442394367358346350336324309589
Medicare Part A($M)
319310309297270265263273256235235245
Private and Other($M)
12311312298.578.212412411496.410698.4132
Medicare Part B($M)
21.730.621.821.320.420.12126.820.524.823.821.7
Kỳ báo cáo trước đây (báo cáo lần cuối 2026)2
Prescriptions Dispensed2
10,949,87510,844,03810,729,87610,844,78610,793,21910,851,77310,877,29410,967,46310,874,42910,120,1979,854,4959,590,754
Prescriptions Dispensed — YoY Growth(%)
1.5%-0.1%-1.4%-1.0%-0.7%7.2%10.4%14.5%9.1%9.2%
Specialty & Infusion Script Volume — YoY Growth(%)
29.0%31.0%30.0%30.0%
Revenue per Script($)1
341314296291275257233219208209201
Revenue per Script — YoY Growth(%)
24.0%22.2%27.0%33.0%31.9%23.1%16.0%18.3%21.3%23.5%
Gross Profit per Script($)1
28.8627.5028.0323.5222.7621.5418.7518.6517.3418.0617.24
Gross Profit per Script — YoY Growth(%)
26.8%27.7%49.5%26.0%31.3%19.3%8.8%0.9%-10.7%-2.8%
Limited Distribution Drugs (LDDs) — Total Portfolio Supported
162155153149
Specialty Pharmacy Medication Possession Ratio (MPR)(%)1
93.0%93.0%92.1%92.4%
Specialty Pharmacy Average Time to First Fill(ngày)
4454
Home & Community Pharmacy Order Completeness Rate(%)1
98.2%99.0%99.0%99.3%
Home & Community Pharmacy On-Time Delivery Rate(%)
91.9%94.3%96.0%96.8%
Home Health Care Average Daily Census (ADC)3
47,25646,44846,06634,59329,98030,08530,24130,01928,65028,28027,093
Home Health Care ADC — YoY Growth(%)
57.6%54.4%52.3%15.0%3.3%6.4%11.6%
Home Health Branches Rated 4+ CMS Quality Stars(%)
96.0%93.2%91.4%
Home Health Timely Initiation of Care Rate(%)
99.0%98.9%99.2%99.4%
Rehab Care Persons Served1
7,5747,7557,6207,3636,9327,1196,6976,5446,5716,7286,546
Rehab Care Persons Served — YoY Growth(%)
9.3%8.9%13.8%13.0%11.4%5.8%2.3%
Personal Care Persons Served2
16,32016,35716,07916,17516,13416,13815,86315,87415,91015,93215,798
Personal Care Persons Served — YoY Growth(%)
1.2%1.4%1.4%2.0%1.4%1.3%0.4%
Personal Care Client Satisfaction Score (Out of 5.0)(×)
4.604.604.604.604.50
Hospice CAHPS Overall Care Rating(%)
86.0%89.0%87.0%87.0%
Clinical Providers & Pharmacists (Continuing Operations)
12,70012,70012,40010,50010,50010,000
Specialty & Infusion Pharmacy Revenue($M)1
3,1802,8682,6442,5642,3772,2031,9521,7961,6781,5861,4661,270
Specialty & Infusion Share of Consolidated Revenue(%)
75.5%74.1%73.2%71.3%70.0%67.7%64.5%65.1%64.2%
Home & Community Pharmacy Revenue($M)2
553540527593590587581601588528511516
Home & Community Pharmacy Share of Consolidated Revenue(%)
13.1%13.9%14.6%17.7%18.6%20.3%22.6%21.6%22.3%
Total Pharmacy Solutions Share of Consolidated Revenue(%)
88.6%88.0%87.8%89.0%88.6%88.0%87.1%86.7%86.5%
Pharmacy Solutions Segment Gross Profit($M)1
316298301255246234204205189183170171
Pharmacy Solutions Segment Gross Margin(%)
8.5%8.8%9.5%8.3%8.4%8.1%8.3%8.6%8.6%
Home Health Care Sub-Segment Revenue($M)2
288278266215189185178182168158148
Acquired Amedisys & LHC Branches Revenue Contribution($M)
767879
Home Health Care Share of Consolidated Revenue(%)
6.9%7.2%7.3%5.6%5.9%6.2%6.5%6.5%6.6%
Rehab Care Sub-Segment Revenue($M)1
81.881.974.876.875.573.269.869.770.27066.7
Rehab Care Share of Consolidated Revenue(%)
1.9%2.1%2.1%2.3%2.3%2.4%2.6%2.8%2.8%
Personal Care Sub-Segment Revenue($M)2
11110710210210299.997.798.197.196.294.5
Personal Care Share of Consolidated Revenue(%)
2.6%2.7%2.8%3.1%3.2%3.4%3.8%4.0%4.1%
Total Provider Services Share of Consolidated Revenue(%)
11.4%12.0%12.2%11.0%11.4%12.0%12.9%13.3%13.5%
Consolidated Adjusted EBITDA (Continuing Operations)($M)2
228206190184160143131130117111102
Total Segment EBITDA($M)2
281255235227202181167168151145135
Pharmacy Solutions Segment EBITDA($M)
20218016916214112511611399.294.588.2
Provider Services Segment EBITDA($M)
7974.96664.460.756.551.155.652.350.746.8
Unallocated Corporate Costs (EBITDA Reconciliation)($M)
5349454341393638343433
Pharmacy Solutions Segment Operating Income($M)2
17615514413611597.788.284.171.267.360.963.7
Pharmacy Solutions Segment SG&A Expenses($M)
140144157119131136116120117116109
Pharmacy Solutions Segment Depreciation & Amortization($M)
25.825.525.326.226.52727.528.727.927.227.2
Provider Services Segment Operating Income (Continuing Operations)($M)2
74665958.353.349.344.348.94644.741
Provider Services Segment SG&A Expenses($M)
12912912299.39391.990.185.388.584.781.5
Provider Services Segment Depreciation & Amortization($M)
58.8076.207.307.206.806.706.3065.70
Adjusted Diluted Earnings per Share (Adjusted EPS)($)
0.540.450.390.330.300.220.190.130.030.060.09
Top 10 Operating States Share of Consolidated Revenue(%)1
52.0%53.0%52.0%53.0%53.0%53.0%52.0%52.0%54.0%
Top 10 Medicaid States Share of Consolidated Revenue(%)
7.0%7.0%6.0%7.0%6.0%6.0%7.0%7.0%7.0%
Full-Year Total Revenue Guidance — Low End (Issued in Quarter)($M)7
15,90015,10014,72514,45012,50012,20012,000
Full-Year Total Revenue Guidance — High End($M)
16,12515,42515,22515,00012,80012,60012,500
Full-Year Pharmacy Revenue Guidance — Low End($M)
14,00013,20012,85012,60011,05010,75010,550
Full-Year Pharmacy Revenue Guidance — High End($M)
14,20013,50013,30013,10011,30011,10011,000
Full-Year Provider Revenue Guidance — Low End($M)
1,9001,9001,8751,8501,4501,4501,450
Full-Year Provider Revenue Guidance — High End($M)
1,9251,9251,9251,9001,5001,5001,500
Full-Year Adjusted EBITDA Guidance — Low End($M)
850820795760605590570
Full-Year Adjusted EBITDA Guidance — High End($M)
860845825790615605585
Credit Agreement Net Leverage Ratio(×)
1.792.152.272.993.313.643.874.164.394.514.335.86
Total Available Liquidity (Period-End)($M)2
1,1941,0271,366566618548531476417437526431
Revolving Credit & LC Facility Availability($M)
476476477477477478478415381412468418
Outstanding Letters of Credit under LC Facility($M)
63.963.962.962.862.861.861.861.8-62-54.2-54.354.3
Goodwill — Pharmacy Solutions Segment($M)1
841841841841841841841841841841835834
Goodwill — Provider Services Segment($M)
1,6961,6941,6931,7051,5301,5291,5291,5231,8321,7851,7741,467
Indefinite-Lived Healthcare Licenses & Certificates of Need($M)1
192192193193137136136136135118118118
Finite-Lived Intangible Assets, Net($M)6
300323344364384409433460708733738763
Customer Relationships, Net($M)
106120133146163177192207321339339353
Trade Names, Net($M)
146153159164173180187193200201207212
Doctor & Payor Relationships, Net($M)
0.300.400.500.700.8011.201.802.302.803.403.90
Licensing Agreements, Net($M)
44.946.147.448.542.544.64650.9176180178183
Non-Compete Agreements, Net($M)
1.501.401.601.902.302.502.902.903.404.104.304.60
Other Finite-Lived Intangible Assets, Net($M)
1.802.202.6033.403.804.204.6055.405.806.10
Option Care Health, Inc. (OPCH — Home & Alternate-Site Infusion) — Consolidated Revenue($M)1
1,4941,4421,3511,4651,4351,4161,3331,3461,2791,2271,1461,124
Option Care Health, Inc. — Operating Income($M)
898573928583798785816985
Chemed Corporation (CHE — VITAS Hospice) — Consolidated Revenue($M)1
691673658639625619647640606596589586
Chemed Corporation — Operating Income($M)
968985101756895114928872111
The Pennant Group, Inc. (PNTG — Home Health, Hospice & Senior Living) — Consolidated Revenue($M)1
302298285289229220210189181169157146
The Pennant Group, Inc. — Operating Income($M)
171717171012139111098
Addus HomeCare Corporation (ADUS — Personal Care, Hospice & Home Health) — Consolidated Revenue($M)1
388377364373362349338297290287281276
Addus HomeCare Corporation — Operating Income($M)
403934423333312726262428
The Ensign Group, Inc. (ENSG — Post-Acute & Skilled Nursing) — Consolidated Revenue($M)1
1,4841,4401,3891,3611,2961,2281,1731,1321,0821,0361,010959
The Ensign Group, Inc. — Operating Income($M)
1381231251249610410110189868223
Encompass Health Corporation (EHC — Inpatient & Post-Acute Rehabilitation) — Consolidated Revenue($M)
1,6101,5971,5871,5451,4781,4581,4551,4051,3511,3011,3161,247
Consolidated Net Revenue($M)3
4,2133,8733,6143,5513,3343,1482,8782,7472,6012,4382,2861,239
Consolidated Gross Profit($M)
51949348241339237533833932331229373.9
Selling, General and Administrative Expenses($M)
35836236130430432628828329427430894.7
Consolidated Operating Income($M)
16113012110887.848.650.755.529.138.7-15.3-20.8
Income (Loss) from Continuing Operations($M)3
10186.774.449.338.19.209.704.90-24.99-55.4
Income (Loss) from Discontinued Operations, Net of Tax($M)
-0.50-2.4074.327.817.81919.811.116.7119.60
Net Income (Loss) Attributable to BrightSpring Health Services, Inc.($M)
10084.314977.155.828.229.516-8.2019.9-45.8-6.50
GAAP Diluted Earnings (Loss) per Common Share($)
0.450.380.670.260.130.14-0.040.10-0.26
Total Consolidated Assets($M)6
6,2675,9866,2136,4136,0505,9445,8475,9265,7865,6055,6565,533
Cash and Cash Equivalents($M)
71855088988.414070.152.36135.522.855.512.4
Accounts Receivable, Net($M)
1,2161,1391,1149901,0139739759031,026985991882
Inventories($M)
672575560815639626534637478374374403
Goodwill (Consolidated)($M)
2,5372,5352,5342,5462,3712,3702,3702,3642,6732,6262,6092,301
Intangible Assets, Net (Consolidated)($M)
492514537558522544568595843851856882
Operating Lease Right-of-Use Assets($M)
170167173172160164162161259259276267
Total Consolidated Debt4
Long-Term Debt, Net of Current Portion($M)
2,1472,1492,4452,4552,4652,4782,4892,5622,6092,5642,5153,332
Total Consolidated Liabilities($M)
4,0813,9284,2234,5274,2294,1984,1564,2754,1673,9994,0814,920
Total Stockholders' Equity($M)
2,1772,0491,9791,8751,8191,7431,6871,6481,6151,6001,568585
Common Shares Outstanding (Period-End)(M)
199198193192181177175174174171171118
Net Cash Provided by (Used in) Operating Activities($M)2
20443.912323210849.110290.627.2-15.2-78.9162
Capital Expenditures (Purchases of Property and Equipment)($M)
22.12921.537.715.824.417.615.32023.721.816.8
Cash Paid for Acquisitions, Net of Cash Acquired($M)
1.90-042.21961.60-06.80016.134.29.400.50

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • Fiscal Calendar & Reporting Scope: BrightSpring Health Services, Inc. operates on a calendar fiscal year ending December 31 (Q1 ends March 31, Q2 ends June 30, Q3 ends September 30, Q4 ends December 31). Latest company filings included: Q3 2026 Form 10-Q and Form 8-K Item 2.02 (ended September 30, 2026, filed October 30, 2026), Q3 2026 Earnings Call Transcript, 2026 Clinical Quality Reports, 2026 Definitive Proxy Statement (DEF 14A), and FY2025 Form 10-K (ended December 31, 2025, filed February 27, 2026). External BLS Producer Price Index and Employment series are updated monthly through October 2026 (2026-10), one month ahead of Q3 2026 company filings.
  • Continuing Operations & Segment Realignment: On January 20, 2025, BrightSpring entered into a definitive agreement to divest its Community Living business to Sevita, which closed on March 30, 2026 ($835.0 million gross cash consideration; $810.9 million cash proceeds). Provider Services operational metrics, sub-segment revenues, and consolidated Non-GAAP measures are presented on a continuing-operations basis from Q1 2024 / FY2023 forward (Home Health Care, Rehab Care, and Personal Care). Pharmacy Solutions was unaffected by the Community Living divestiture and spans FY2020–FY2025 and Q4 2022–Q3 2026. Effective July 1, 2026, the Rehab in Motion business shifted from Rehab Care to Home Health Care with Q3 2025 and 9M 2025 comparables recast.
  • Parent-Company Schedule I Evaluation: Under U.S. GAAP, BrightSpring Health Services, Inc. is a holding company with no standalone operating revenue or operational volume disclosures outside consolidated subsidiaries; condensed parent-only financial information (Schedule I) is an annual holding-company equity summary, so Consolidated minus Parent-Only subtraction does not apply.
  • Data Integrity & Permitted Period Splits: Every cell presents an exact published figure from BrightSpring SEC filings, earnings call transcripts, clinical quality reports, or official U.S. statistical/regulatory agencies (BLS, U.S. Census Bureau, and peer SEC XBRL filings), plus permitted standalone-quarter subtractions from cumulative year-to-date disclosures (Q4 = full year − nine months and cash flow year-to-date splits, explicitly annotated with formula). Directional bounds ('over 23,500 FTEs', 'over 485,000 patients daily', 'over 175 pharmacies') are excluded from numeric cells.

Không hiện vì thiếu các kỳ gần đây (7)

  • Total Employees / FTE Headcount, Daily Patients Served, Pharmacy Locations & Customer Contracts (disclosed primarily as directional bounds such as 'over 23,500 FTEs', 'over 485,000 patients daily', 'over 175 pharmacies, infusion centers, and specialty oncology clinics', and 'over 4,500 contracts', which are ineligible as point values)
  • Union-Represented FTE Headcount & Owned/Leased Property Counts across 2023–2025 Form 10-Ks (subject to an un-recast scope break at year-end 2025 when Community Living was reclassified to held-for-sale / discontinued operations, reducing union FTEs from ~7,200 total company in FY2024 to ~3,500 continuing operations in FY2025)
  • Pre-Divestiture Provider Services Metrics — Historical Community and Rehab Care Persons Served & Pre-Recast Home Health Care ADC including Personal Care (superseded in Q1 2025 upon the Community Living divestiture agreement and recast into continuing-operations Home Health Care ADC, Rehab Care Persons Served, and Personal Care Persons Served)
  • Home & Community Pharmacy Dispensing Accuracy Rate on Quarterly Calls (reported for Q4 2025, Q1 2026, and Q2 2026 at 99.98%–99.99%, but omitted on the Q3 2026 earnings call; annual enterprise pharmacy order accuracy from Form 10-K is retained in Group 1)
  • Quarterly Branded LDD Launch Counts on Earnings Calls (management alternated between total LDD launches in Q4 2025 and Q3 2026 versus narrow 'exclusive / ultra-narrow LDDs added' in Q1 2026 and Q2 2026; period-end Total LDD Portfolio Supported is consistent across all four quarters and retained in Group 1)
  • U.S. Census Bureau Quarterly Services Survey — Home Health Care Services Revenue (FRED REV6216TAXABL144QNSA; publication paused after Q1 2025 with missing 2024 quarters, replaced by continuous monthly BLS Home Health PPI and Employment through October 2026)
  • Aveanna Healthcare Holdings Inc. (AVAH) XBRL Series & Encompass Health (EHC) Operating Income (Aveanna uses a non-calendar 52/53-week fiscal year causing fiscal quarter key misalignment against BrightSpring's December 31 calendar quarters, and Encompass Health changed its XBRL operating income tag after FY2022)

Dữ liệu cập nhật 2026-11-14.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của BrightSpring Health Services

See a number that looks wrong?